HNB
ALNY icon

Huntington National Bank’s Alnylam Pharmaceuticals ALNY Stock Holding History

Huntington National Bank’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$38.2K Buy
127
+8
+7% +$2.41K ﹤0.01% 1531
2026
Q1 		$39.4K Buy
119
+17
+17% +$5.79K ﹤0.01% 1426
2025
Q4 		$40.6K Buy
102
+1
+1% +$443 ﹤0.01% 1332
2025
Q3 		$46.1K Sell
101
-94
-48% -$38.3K ﹤0.01% 1296
2025
Q2 		$63.6K Sell
195
-3
-2% -$830 ﹤0.01% 1153
2025
Q1 		$53.5K Buy
198
+125
+171% +$32.1K ﹤0.01% 1153
2024
Q4 		$17.2K Sell
73
-21
-22% -$5.52K ﹤0.01% 1588
2024
Q3 		$25.9K Buy
94
+45
+92% +$11.7K ﹤0.01% 1430
2024
Q2 		$11.9K Sell
49
-18
-27% -$2.84K ﹤0.01% 1630
2024
Q1 		$10K Buy
67
+35
+109% +$5.84K ﹤0.01% 1679
2023
Q4 		$6.13K Buy
32
+2
+7% +$341 ﹤0.01% 1823
2023
Q3 		$5.31K Sell
30
-12
-29% -$2.29K ﹤0.01% 1790
2023
Q2 		$7.98K Buy
42
+23
+121% +$4.56K ﹤0.01% 1644
2023
Q1 		$3.81K Buy
19
+18
+1,800% +$3.78K ﹤0.01% 1804
2022
Q4 		$238 Buy
+1
New +$213 ﹤0.01% 1986
2022
Q1 		– Sell
-81
Closed -$14K – 2026
2021
Q4 		$14K Sell
81
-5
-6% -$929 ﹤0.01% 1480
2021
Q3 		$16K Buy
86
+5
+6% +$938 ﹤0.01% 1313
2021
Q2 		$14K Hold
81
– – ﹤0.01% 1358
2021
Q1 		$11K Buy
+81
New +$12.2K ﹤0.01% 1306
2020
Q2 		– Sell
-296
Closed -$32K – 1488
2020
Q1 		$32K Hold
296
– – ﹤0.01% 920
2019
Q4 		$34K Buy
+296
New +$29.5K ﹤0.01% 1062
2019
Q1 		– Sell
-1,000
Closed -$73K – 1537
2018
Q4 		$73K Buy
+1,000
New +$76.9K ﹤0.01% 738
2013
Q4 		– Sell
-2,750
Closed -$176K – 1709
2013
Q3 		$176K Sell
2,750
-250
-8% -$12.5K 0.01% 712
2013
Q2 		$93K Buy
+3,000
New +$79.8K ﹤0.01% 873

Other funds holding ALNY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Huntington National Bank's ALNY Position: Q2 2026 in Review

Huntington National Bank increased its Alnylam Pharmaceuticals (ALNY) stake by 6.7% in Q2 2026, buying an estimated $2.41K and bringing the position to 127 shares worth $38.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1531.

Huntington National Bank first reported a position in ALNY in Q2 2013 and has held it in 24 quarters since. The position peaked at $176K in Q3 2013. 793 funds tracked by Wall St. Rank hold ALNY as of Q2 2026.

  • Huntington National Bank held 127 shares of Alnylam Pharmaceuticals worth $38.2K as of Q2 2026.
  • Huntington National Bank bought 8 Alnylam Pharmaceuticals shares in Q2 2026, an estimated $2.41K.
  • Alnylam Pharmaceuticals made up ﹤0.01% of Huntington National Bank's portfolio in Q2 2026, its #1531 holding.
  • Huntington National Bank first reported a position in Alnylam Pharmaceuticals in Q2 2013 and has held it in 24 quarters since.
  • Huntington National Bank's Alnylam Pharmaceuticals position peaked at $176K in Q3 2013.
  • 793 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q2 2026.

Based on Huntington National Bank's 13F filing for Q2 2026, filed 13 Aug 2026.